Browsing Tag
Paige
2 posts
Tempus (Nasdaq: TEM) gains real-world NHS evidence for Paige Prostate AI, but scale-up still depends on economics
Prospective NHS deployment strengthens the clinical case for Tempus AI’s digital pathology portfolio, although cost effectiveness, infrastructure readiness and commercial conversion remain unproven.
The business of AI in oncology: Who’s building the platforms hospitals trust?
Tempus, Guardant, Freenome, and Paige are building the AI oncology platforms hospitals now rely on. Discover the financials and future shaping cancer diagnostics.